Bachleda Mark
- SEC CIK
- 0001887762
No open-market purchases or sales filed in the past year.
Current role at each company
- LYEL Lyell Immunopharma, Inc.Directoras of Jun 12, 2026
- GRTX Galera Therapeutics, Inc.Chief Commercial Officeras of Mar 20, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Bachleda Mark as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
GRTX Galera Therapeutics, Inc.
Chief Commercial Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 20, 2023 (view filing) | Mar 16 | 4 days | Bachleda MarkChief Commercial Officer | PPurchase | +11.0K | $2.25 | +$24.8K | New position11.0K after |